Nonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications [Original Articles]

Conclusions—
Approximately 40% of HCM probands have a nonfamilial subtype, with later onset and less severe clinical course. We propose a revised clinical pathway for management, highlighting the role of genetic testing, a detailed pedigree, and refined clinical surveillance recommendations for family members.

Source: Circulation: Cardiovascular Genetics - April 13, 2017 Category: Cardiology Authors: Ingles, J., Burns, C., Bagnall, R. D., Lam, L., Yeates, L., Sarina, T., Puranik, R., Briffa, T., Atherton, J. J., Driscoll, T., Semsarian, C. Tags: Genetics, Cardiomyopathy, Hypertrophy Original Articles Source Type: research